- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Decapping protein 2 (DCP2) is a key cytoplasmic enzyme that catalyzes the removal of the 5' cap structure from messenger RNA, a critical step in mRNA degradation and turnover. The DCP2 Antibody / mRNA Decapping Enzyme Antibody is designed to detect this central regulator of RNA stability in biological systems where gene expression control and RNA processing are of interest. DCP2 is encoded on chromosome 5q22 and functions as the catalytic core of the mRNA decapping complex. This antibody is part of a collection of Human Protein Microarray validated antibodies that have been screened for specificity across thousands of proteins.
The DCP2 antibody, also referred to as Decapping protein 2 antibody in the literature, recognizes a protein that localizes primarily to the cytoplasm, where it is enriched in processing bodies (P-bodies). These cytoplasmic RNA granules serve as sites of mRNA storage, degradation, and translational repression. DCP2 works in coordination with cofactors such as DCP1 and other decapping activators to regulate the stability and turnover of mRNA transcripts.
This DCP2 Antibody / mRNA Decapping Enzyme Antibody is uniquely positioned for studies of post-transcriptional gene regulation and RNA metabolism. By controlling the removal of the 5' cap, DCP2 commits mRNA molecules to degradation, thereby influencing gene expression levels and cellular responses to environmental and developmental cues. In immunofluorescence applications, DCP2 is often observed as punctate cytoplasmic staining corresponding to P-bodies, while western blot analysis detects the protein at its expected molecular weight in a variety of cell types.
DCP2 plays an important role in multiple biological processes, including stress responses, cell differentiation, and maintenance of RNA homeostasis. Dysregulation of mRNA decay pathways has been linked to cancer, viral infection, and neurodegenerative disease, where altered RNA stability can impact protein expression and cellular function. As a result, DCP2 serves as a key marker for studying RNA turnover and post-transcriptional control mechanisms.
The mouse monoclonal clone PCRP-DCP2-1D6 provides consistent detection of DCP2 in research applications focused on RNA processing and mRNA decay. This DCP2 Antibody / mRNA Decapping Enzyme Antibody is suitable for detecting DCP2 expression in studies of gene regulation, RNA granule biology, and cellular stress responses. Its performance supports detailed evaluation of mRNA turnover pathways in both normal and disease-associated contexts.
This antibody supports investigation of mRNA decay, RNA processing, and post-transcriptional regulation involving DCP2.
This antibody is part of a broader antibody panel offered by NSJ Bioreagents.
Optimal dilution of the DCP2 Antibody / mRNA Decapping Enzyme Antibody should be determined by the researcher.
Recombinant full-length human protein was used as the immunogen for the Decapping Protein 2 antibody.
Aliquot the Decapping Protein 2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
DCP2 antibody, Decapping protein 2 antibody, mRNA decapping enzyme antibody, DCP2 RNA processing antibody, DCP2 P-body protein antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.